The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity

British Journal of Haematology

Volumn 164, Issue 2, 2014, Pages 165-176

  Xie, Hongxiang ^a,b   Sheng, Liangju ^b   Zhou, Hong ^a,b   Yan, Jinchuan ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Antiphospholipid syndrome; Beta 2 glycoprotein I; Coagulation factor III (tissue factor); Nuclear factor B; Toll like receptor 4

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 RECEPTOR; CALRETICULIN; IMMUNOGLOBULIN G; RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; CELL ACTIVATION; CELL SURFACE; ENDOTHELIUM CELL; GENETIC POLYMORPHISM; HUMAN; IMMUNOMODULATION; MATERNAL MORBIDITY; MOLECULAR RECOGNITION; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TOLL LIKE RECEPTOR 4 GENE;

ANTIPHOSPHOLIPID SYNDROME; BETA-2 GLYCOPROTEIN I; COAGULATION FACTOR III (TISSUE FACTOR); NUCLEAR FACTOR-ΚB; TOLL-LIKE RECEPTOR 4;

ANNEXIN A2; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CELL MEMBRANE; FEMALE; HUMANS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS; SIGNAL TRANSDUCTION; THROMBOSIS; TOLL-LIKE RECEPTOR 4;

EID: 84891634809     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12587     Document Type: Review

References (108)

1. Agar, C., van Os, G.M., Morgelin, M., Sprenger, R.R., Marquart, J.A., Urbanus, R.T., Derksen, R.H., Meijers, J.C. & de Groot, P.G. (2010) Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood, 116, 1336-1343.
2. Alard, J.E., Gaillard, F., Daridon, C., Shoenfeld, Y., Jamin, C. & Youinou, P. (2010) TLR2 is one of the endothelial receptors for beta 2-glycoprotein I. Journal of Immunology, 185, 1550-1557.
3. Allen, K.L., Fonseca, F.V., Betapudi, V., Willard, B., Zhang, J. & McCrae, K.R. (2012) A novel pathway for human endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood, 119, 884-893.
4. Arad, A., Proulle, V., Furie, R.A., Furie, B.C. & Furie, B. (2011) beta(2)-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood, 117, 3453-3459.
5. Arbour, N.C., Lorenz, E., Schutte, B.C., Zabner, J., Kline, J.N., Jones, M., Frees, K., Watt, J.L. & Schwartz, D.A. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genetics, 25, 187-191.
6. Aronovich, R., Gurwitz, D., Kloog, Y. & Chapman, J. (2005) Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms. Immunobiology, 210, 781-788.
7. Asherson, R.A., Cervera, R., de Groot, P.G., Erkan, D., Boffa, M.C., Piette, J.C., Khamashta, M.A. & Shoenfeld, Y. (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus, 12, 530-534.
8. Atsumi, T., Amengual, O., Yasuda, S., Matsuura, E. & Koike, T. (2005) Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies. Autoimmunity, 38, 377-381.
9. Avalos, I. & Tsokos, G.C. (2009) The role of complement in the antiphospholipid syndrome-associated pathology. Clinical Reviews in Allergy and Immunology, 36, 141-144.
10. Bell, J.K., Mullen, G.E., Leifer, C.A., Mazzoni, A., Davies, D.R. & Segal, D.M. (2003) Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends in Immunology, 24, 528-533.
11. Berthet, J., Damien, P., Hamzeh-Cognasse, H., Arthaud, C.A., Eyraud, M.A., Zeni, F., Pozzetto, B., McNicol, A., Garraud, O. & Cognasse, F. (2012) Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clinical Immunology, 145, 189-200.
12. Bohgaki, M., Atsumi, T., Yamashita, Y., Yasuda, S., Sakai, Y., Furusaki, A., Bohgaki, T., Amengual, O., Amasaki, Y. & Koike, T. (2004) The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies. International Immunology, 16, 1633-1641.
13. Boles, J. & Mackman, N. (2010) Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Lupus, 19, 370-378.
14. Bose, P., Black, S., Kadyrov, M., Weissenborn, U., Neulen, J., Regan, L. & Huppertz, B. (2005) Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. American Journal of Obstetrics and Gynecology, 192, 23-30.
15. Bose, P., Kadyrov, M., Goldin, R., Hahn, S., Backos, M., Regan, L. & Huppertz, B. (2006) Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta, 27, 869-875.
16. Buttari, B., Profumo, E., Mattei, V., Siracusano, A., Ortona, E., Margutti, P., Salvati, B., Sorice, M. & Rigano, R. (2005) Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood, 106, 3880-3887.
17. Cervera, R. & Balasch, J. (2008) Bidirectional effects on autoimmunity and reproduction. Human Reproduction Update, 14, 359-366.
18. Cervera, R., Boffa, M.C., Khamashta, M.A. & Hughes, G.R. (2009a) The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus, 18, 889-893.
19. Cervera, R., Khamashta, M.A., Shoenfeld, Y., Camps, M.T., Jacobsen, S., Kiss, E., Zeher, M.M., Tincani, A., Kontopoulou-Griva, I., Galeazzi, M., Bellisai, F., Meroni, P.L., Derksen, R.H., de Groot, P.G., Gromnica-Ihle, E., Baleva, M., Mosca, M., Bombardieri, S., Houssiau, F., Gris, J.C., Quere, I., Hachulla, E., Vasconcelos, C., Roch, B., Fernandez-Nebro, A., Piette, J.C., Espinosa, G., Bucciarelli, S., Pisoni, C.N., Bertolaccini, M.L., Boffa, M.C. & Hughes, G.R. (2009b) Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Annals of the Rheumatic Diseases, 68, 1428-1432.
20. Christian, S., Pilch, J., Akerman, M.E., Porkka, K., Laakkonen, P. & Ruoslahti, E. (2003) Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. Journal of Cell Biology, 163, 871-878.
21. Clanchy, F.I. & Sacre, S.M. (2010) Modulation of toll-like receptor function has therapeutic potential in autoimmune disease. Expert Opin Biol Ther, 10, 1703-1716.
22. Cohen, S.B., Cheng, T.T., Chindalore, V., Damjanov, N., Burgos-Vargas, R., Delora, P., Zimany, K., Travers, H. & Caulfield, J.P. (2009) Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Arthritis and Rheumatism, 60, 335-344.
23. Colasanti, T., Alessandri, C., Capozzi, A., Sorice, M., Delunardo, F., Longo, A., Pierdominici, M., Conti, F., Truglia, S., Siracusano, A., Valesini, G., Ortona, E. & Margutti, P. (2012) Autoantibodies specific to a peptide of beta2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood, 120, 3360-3370.
24. Conti, F., Sorice, M., Circella, A., Alessandri, C., Pittoni, V., Caronti, B., Calderaro, C., Griggi, T., Misasi, R. & Valesini, G. (2003) Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression. Clinical and Experimental Immunology, 132, 509-516.
25. De Angelis, V., Scurati, S., Raschi, E., Liutkus, A., Belot, A., Borghi, M.O., Meroni, P.L. & Cimaz, R. (2009) Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: report of a family with multiple anti-phospholipid positive members. Journal of Autoimmunity, 32, 60-63.
26. Derksen, R.H. & de Groot, P.G. (2008) The obstetric antiphospholipid syndrome. Journal of Reproductive Immunology, 77, 41-50.
27. Dunoyer-Geindre, S., de Moerloose, P., Galve-de Rochemonteix, B., Reber, G. & Kruithof, E.K. (2002) NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies. Thrombosis and Haemostasis, 88, 851-857.
28. Erridge, C. (2010) Endogenous ligands of TLR2 and TLR4: agonists or assistants? Journal of Leukocyte Biology, 87, 989-999.
29. Espinosa, G. & Cervera, R. (2009) Thromboprophylaxis and obstetric management of the antiphospholipid syndrome. Expert Opinion on Pharmacotherapy, 10, 601-614.
30. Fischetti, F., Durigutto, P., Pellis, V., Debeus, A., Macor, P., Bulla, R., Bossi, F., Ziller, F., Sblattero, D., Meroni, P. & Tedesco, F. (2005) Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood, 106, 2340-2346.
31. Galarza-Maldonado, C., Kourilovitch, M.R., Perez-Fernandez, O.M., Gaybor, M., Cordero, C., Cabrera, S. & Soroka, N.F. (2012) Obstetric antiphospholipid syndrome. Autoimmunity Reviews, 11, 288-295.
32. Galli, M., Luciani, D., Bertolini, G. & Barbui, T. (2003) Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood, 102, 2717-2723.
33. Giannakopoulos, B., Passam, F., Rahgozar, S. & Krilis, S.A. (2007) Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood, 109, 422-430.
34. Girardi, G. & Mackman, N. (2008) Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule. Lupus, 17, 931-936.
35. Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J.M., Kraus, D., Hollmann, T.J., Casali, P., Caroll, M.C., Wetsel, R.A., Lambris, J.D., Holers, V.M. & Salmon, J.E. (2003) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. Journal of Clinical Investigation, 112, 1644-1654.
36. Gladigau, G., Haselmayer, P., Scharrer, I., Munder, M., Prinz, N., Lackner, K., Schild, H., Stein, P. & Radsak, M.P. (2012) A role for toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome. PLoS ONE, 7, e42176.
37. de Groot, P.G. & Meijers, J.C. (2011) beta(2) - Glycoprotein I: evolution, structure and function. Journal of Thrombosis and Haemostasis, 9, 1275-1284.
38. de Groot, P.G., Derksen, R.H. & Urbanus, R.T. (2010) The role of LRP8 (ApoER2′) in the pathophysiology of the antiphospholipid syndrome. Lupus, 19, 389-393.
39. Guiducci, C., Gong, M., Xu, Z., Gill, M., Chaussabel, D., Meeker, T., Chan, J.H., Wright, T., Punaro, M., Bolland, S., Soumelis, V., Banchereau, J., Coffman, R.L., Pascual, V. & Barrat, F.J. (2010) TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature, 465, 937-941.
40. Hills, F.A., Abrahams, V.M., Gonzalez-Timon, B., Francis, J., Cloke, B., Hinkson, L., Rai, R., Mor, G., Regan, L., Sullivan, M., Lam, E.W. & Brosens, J.J. (2006) Heparin prevents programmed cell death in human trophoblast. Molecular Human Reproduction, 12, 237-243.
41. Holers, V.M., Girardi, G., Mo, L., Guthridge, J.M., Molina, H., Pierangeli, S.S., Espinola, R., Xiaowei, L.E., Mao, D., Vialpando, C.G. & Salmon, J.E. (2002) Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. Journal of Experimental Medicine, 195, 211-220.
42. Holoshitz, J., De Almeida, D.E. & Ling, S. (2010) A role for calreticulin in the pathogenesis of rheumatoid arthritis. Annals of the New York Academy of Sciences, 1209, 91-98.
43. Ioannou, Y., Romay-Penabad, Z., Pericleous, C., Giles, I., Papalardo, E., Vargas, G., Shilagard, T., Latchman, D.S., Isenberg, D.A., Rahman, A. & Pierangeli, S. (2009) In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept. Journal of Thrombosis and Haemostasis, 7, 833-842.
44. Kajiwara, T., Yasuda, T. & Matsuura, E. (2007) Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome. Journal of Autoimmunity, 29, 164-173.
45. Kobayashi, K., Matsuura, E., Liu, Q., Furukawa, J., Kaihara, K., Inagaki, J., Atsumi, T., Sakairi, N., Yasuda, T., Voelker, D.R. & Koike, T. (2001) A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. Journal of Lipid Research, 42, 697-709.
46. Kotzin, B.L. (1996) Systemic lupus erythematosus. Cell, 85, 303-306.
47. Kurt-Jones, E.A., Popova, L., Kwinn, L., Haynes, L.M., Jones, L.P., Tripp, R.A., Walsh, E.E., Freeman, M.W., Golenbock, D.T., Anderson, L.J. & Finberg, R.W. (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nature Immunology, 1, 398-401.
48. de Laat, B., Derksen, R.H., van Lummel, M., Pennings, M.T. & de Groot, P.G. (2006) Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. Blood, 107, 1916-1924.
49. de Laat, B., Pengo, V., Pabinger, I., Musial, J., Voskuyl, A.E., Bultink, I.E., Ruffatti, A., Rozman, B., Kveder, T., de Moerloose, P., Boehlen, F., Rand, J., Ulcova-Gallova, Z., Mertens, K. & de Groot, P.G. (2009) The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. Journal of Thrombosis and Haemostasis, 7, 1767-1773.
50. Lambrianides, A., Carroll, C.J., Pierangeli, S.S., Pericleous, C., Branch, W., Rice, J., Latchman, D.S., Townsend, P., Isenberg, D.A., Rahman, A. & Giles, I.P. (2010) Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways. Journal of Immunology, 184, 6622-6628.
51. Laplante, P., Amireault, P., Subang, R., Dieude, M., Levine, J.S. & Rauch, J. (2011) Interaction of beta2-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages. Journal of Biological Chemistry, 286, 42494-42503.
52. Levine, J.S., Subang, R., Nasr, S.H., Fournier, S., Lajoie, G., Wither, J. & Rauch, J. (2006) Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus. Journal of Immunology, 177, 6504-6516.
53. Lopez-Pedrera, C., Buendia, P., Cuadrado, M.J., Siendones, E., Aguirre, M.A., Barbarroja, N., Montiel-Duarte, C., Torres, A., Khamashta, M. & Velasco, F. (2006) Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. Arthritis and Rheumatism, 54, 301-311.
54. van Lummel, M., Pennings, M.T., Derksen, R.H., Urbanus, R.T., Lutters, B.C., Kaldenhoven, N. & de Groot, P.G. (2005) The binding site in {beta}2-glycoprotein I for ApoER2′ on platelets is located in domain V. Journal of Biological Chemistry, 280, 36729-36736.
55. Lutters, B.C., Derksen, R.H., Tekelenburg, W.L., Lenting, P.J., Arnout, J. & de Groot, P.G. (2003) Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. Journal of Biological Chemistry, 278, 33831-33838.
56. Ma, K., Simantov, R., Zhang, J.C., Silverstein, R., Hajjar, K.A. & McCrae, K.R. (2000) High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. Journal of Biological Chemistry, 275, 15541-15548.
57. Meroni, P.L., Raschi, E., Testoni, C., Tincani, A. & Balestrieri, G. (2001) Antiphospholipid antibodies and the endothelium. Rheumatic Diseases Clinics of North America, 27, 587-602.
58. Meroni, P.L., Raschi, E., Grossi, C., Pregnolato, F., Trespidi, L., Acaia, B. & Borghi, M.O. (2012) Obstetric and vascular APS: same autoantibodies but different diseases? Lupus, 21, 708-710.
59. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., PG, D.E.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. & Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306.
60. Montiel-Manzano, G., Romay-Penabad, Z., Papalardo de Martinez, E., Meillon-Garcia, L.A., Garcia-Latorre, E., Reyes-Maldonado, E. & Pierangeli, S.S. (2007) In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies. Annals of the New York Academy of Sciences, 1108, 540-553.
61. Mulla, M.J., Brosens, J.J., Chamley, L.W., Giles, I., Pericleous, C., Rahman, A., Joyce, S.K., Panda, B., Paidas, M.J. & Abrahams, V.M. (2009) Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. American Journal of Reproductive Immunology, 62, 96-111.
62. Newton, K. & Dixit, V.M. (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol, 4. doi: 10.1101/cshperspect.a006049.
63. Nickerson, K.M., Christensen, S.R., Shupe, J., Kashgarian, M., Kim, D., Elkon, K. & Shlomchik, M.J. (2010) TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. Journal of Immunology, 184, 1840-1848.
64. O'Neill, L.A. & Bowie, A.G. (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology, 7, 353-364.
65. Ostuni, R., Zanoni, I. & Granucci, F. (2010) Deciphering the complexity of Toll-like receptor signaling. Cellular and Molecular Life Sciences, 67, 4109-4134.
66. Owens, A.P. III & Mackman, N. (2010) Tissue factor and thrombosis: the clot starts here. Thrombosis and Haemostasis, 104, 432-439.
67. Parker, L.C., Prince, L.R. & Sabroe, I. (2007) Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clinical and Experimental Immunology, 147, 199-207.
68. Pennings, M.T., Derksen, R.H., van Lummel, M., Adelmeijer, J., VanHoorelbeke, K., Urbanus, R.T., Lisman, T. & de Groot, P.G. (2007) Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2′. Journal of Thrombosis and Haemostasis, 5, 369-377.
69. Pierangeli, S.S., Vega-Ostertag, M.E., Raschi, E., Liu, X., Romay-Penabad, Z., De Micheli, V., Galli, M., Moia, M., Tincani, A., Borghi, M.O., Nguyen-Oghalai, T. & Meroni, P.L. (2007) Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Annals of the Rheumatic Diseases, 66, 1327-1333.
70. Rai, R.S., Clifford, K., Cohen, H. & Regan, L. (1995) High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Human Reproduction, 10, 3301-3304.
71. Raschi, E., Testoni, C., Bosisio, D., Borghi, M.O., Koike, T., Mantovani, A. & Meroni, P.L. (2003) Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood, 101, 3495-3500.
72. Raschi, E., Borghi, M.O., Grossi, C., Broggini, V., Pierangeli, S. & Meroni, P.L. (2008) Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus, 17, 937-942.
73. Rassa, J.C., Meyers, J.L., Zhang, Y., Kudaravalli, R. & Ross, S.R. (2002) Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proceedings of the National Academy of Sciences of the United States of America, 99, 2281-2286.
74. Rauch, J., Dieude, M., Subang, R. & Levine, J.S. (2010) The dual role of innate immunity in the antiphospholipid syndrome. Lupus, 19, 347-353.
75. Redecha, P., Tilley, R., Tencati, M., Salmon, J.E., Kirchhofer, D., Mackman, N. & Girardi, G. (2007) Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood, 110, 2423-2431.
76. Redecha, P., Franzke, C.W., Ruf, W., Mackman, N. & Girardi, G. (2008) Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. Journal of Clinical Investigation, 118, 3453-3461.
77. Resman, N., Gradisar, H., Vasl, J., Keber, M.M., Pristovsek, P. & Jerala, R. (2008) Taxanes inhibit human TLR4 signaling by binding to MD-2. FEBS Letters, 582, 3929-3934.
78. Riboldi, P., Gerosa, M., Raschi, E., Testoni, C. & Meroni, P.L. (2003) Endothelium as a target for antiphospholipid antibodies. Immunobiology, 207, 29-36.
79. Romay-Penabad, Z., Montiel-Manzano, M.G., Shilagard, T., Papalardo, E., Vargas, G., Deora, A.B., Wang, M., Jacovina, A.T., Garcia-Latorre, E., Reyes-Maldonado, E., Hajjar, K.A. & Pierangeli, S.S. (2009) Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood, 114, 3074-3083.
80. Romay-Penabad, Z., Aguilar-Valenzuela, R., Urbanus, R.T., Derksen, R.H., Pennings, M.T., Papalardo, E., Shilagard, T., Vargas, G., Hwang, Y., de Groot, P.G. & Pierangeli, S.S. (2011) Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood, 117, 1408-1414.
81. Roubey, R.A. (1999) Immunology of the antiphospholipid syndrome: antibodies, antigens, and autoimmune response. Thrombosis and Haemostasis, 82, 656-661.
82. Satta, N., Dunoyer-Geindre, S., Reber, G., Fish, R.J., Boehlen, F., Kruithof, E.K. & de Moerloose, P. (2007) The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood, 109, 1507-1514.
83. Satta, N., Kruithof, E.K., Fickentscher, C., Dunoyer-Geindre, S., Boehlen, F., Reber, G., Burger, D. & de Moerloose, P. (2011) Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood, 117, 5523-5531.
84. Sebire, N.J., Fox, H., Backos, M., Rai, R., Paterson, C. & Regan, L. (2002) Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Human Reproduction, 17, 1067-1071.
85. Sene, D., Piette, J.C. & Cacoub, P. (2008) Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmunity Reviews, 7, 272-277.
86. Shi, T., Giannakopoulos, B., Yan, X., Yu, P., Berndt, M.C., Andrews, R.K., Rivera, J., Iverson, G.M., Cockerill, K.A., Linnik, M.D. & Krilis, S.A. (2006) Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis and Rheumatism, 54, 2558-2567.
87. Shi, H., Huang, Y., Zhou, H., Song, X., Yuan, S., Fu, Y. & Luo, Y. (2007) Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood, 110, 2899-2906.
88. Shoenfeld, Y., Krause, I., Kvapil, F., Sulkes, J., Lev, S., von Landenberg, P., Font, J., Zaech, J., Cervera, R., Piette, J.C., Boffa, M.C., Khamashta, M.A., Bertolaccini, M.L., Hughes, G.R., Youinou, P., Meroni, P.L., Pengo, V., Alves, J.D., Tincani, A., Szegedi, G., Lakos, G., Sturfelt, G., Jonsen, A., Koike, T., Sanmarco, M., Ruffatti, A., Ulcova-Gallova, Z., Praprotnik, S., Rozman, B., Lorber, M., Vriezman, V.B. & Blank, M. (2003) Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome. Journal of Clinical Immunology, 23, 377-383.
89. Shoenfeld, Y., Blank, M., Cervera, R., Font, J., Raschi, E. & Meroni, P.L. (2006) Infectious origin of the antiphospholipid syndrome. Annals of the Rheumatic Diseases, 65, 2-6.
90. Sikara, M.P., Routsias, J.G., Samiotaki, M., Panayotou, G., Moutsopoulos, H.M. & Vlachoyiannopoulos, P.G. (2010) {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome. Blood, 115, 713-723.
91. Simoncini, S., Sapet, C., Camoin-Jau, L., Bardin, N., Harle, J.R., Sampol, J., Dignat-George, F. & Anfosso, F. (2005) Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome. International Immunology, 17, 489-500.
92. Smirnova, I., Hamblin, M.T., McBride, C., Beutler, B. & Di Rienzo, A. (2001) Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics, 158, 1657-1664.
93. Sorice, M., Longo, A., Capozzi, A., Garofalo, T., Misasi, R., Alessandri, C., Conti, F., Buttari, B., Rigano, R., Ortona, E. & Valesini, G. (2007) Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis and Rheumatism, 56, 2687-2697.
94. Tang, S.C., Arumugam, T.V., Xu, X., Cheng, A., Mughal, M.R., Jo, D.G., Lathia, J.D., Siler, D.A., Chigurupati, S., Ouyang, X., Magnus, T., Camandola, S. & Mattson, M.P. (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proceedings of the National Academy of Sciences of the United States of America, 104, 13798-13803.
95. Tincani, A., Andreoli, L., Chighizola, C. & Meroni, P.L. (2009) The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Autoimmunity, 42, 257-259.
96. Urbanus, R.T., Derksen, R.H. & de Groot, P.G. (2008a) Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Reviews, 22, 93-105.
97. Urbanus, R.T., Pennings, M.T., Derksen, R.H. & de Groot, P.G. (2008b) Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2′. Journal of Thrombosis and Haemostasis, 6, 1405-1412.
98. Vega-Ostertag, M.E., Ferrara, D.E., Romay-Penabad, Z., Liu, X., Taylor, W.R., Colden-Stanfield, M. & Pierangeli, S.S. (2007) Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation. Journal of Thrombosis and Haemostasis, 5, 1828-1834.
99. Xia, L., Zhou, H., Hu, L., Xie, H., Wang, T., Xu, Y., Liu, J., Zhang, X. & Yan, J. (2013) Both NF-kappaB and c-Jun/AP-1 involved in anti-beta2GPI/beta2GPI-induced tissue factor expression in monocytes. Thrombosis and Haemostasis, 109, 643-651.
100. Xu, G., Wen, H., Zhou, H., Guo, D., Zhou, F., Chen, D., Xie, H., Wang, T. & Wang, H. (2011) Involvement of IRAKs and TRAFs in anti-beta(2)GPI/beta(2)GPI-induced tissue factor expression in THP-1 cells. Thrombosis and Haemostasis, 106, 1158-1169.
101. Zhang, J. & McCrae, K.R. (2005) Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood, 105, 1964-1969.
102. Zhang, J., Lieske, K., McCrae, B. & McCrae, K.R. (2004) Activation of endothelial cells by β2glycoprotein I (β2GPl) antibodies is mediated by Annexin II cross linking and may involve TLR4. Blood, 104, 83 [abstract].
103. Zhou, H., Wolberg, A.S. & Roubey, R.A. (2004) Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood, 104, 2353-2358.
104. Zhou, H., Ling, S., Yu, Y., Wang, T. & Hu, H. (2007) Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. Cell Research, 17, 737-739.
105. Zhou, H., Wang, H., Li, N., Yu, Y., Huang, H., Yan, Y. & Wang, T. (2009) Annexin A2 mediates anti-beta 2 GPI/beta 2 GPI-induced tissue factor expression on monocytes. International Journal of Molecular Medicine, 24, 557-562.
106. Zhou, H., Yan, Y., Xu, G., Zhou, B., Wen, H., Guo, D., Zhou, F. & Wang, H. (2011) Toll-like receptor (TLR)-4 mediates anti-beta2GPI/beta2GPI-induced tissue factor expression in THP-1 cells. Clinical and Experimental Immunology, 163, 189-198.
107. Zhou, H., Chen, D., Xie, H., Xia, L., Wang, T., Yuan, W. & Yan, J. (2012) Activation of MAPKs in the anti-beta2GPI/beta2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells. Thrombosis Research, 130, e229-e235.
108. Zimmer, S.M., Liu, J., Clayton, J.L., Stephens, D.S. & Snyder, J.P. (2008) Paclitaxel binding to human and murine MD-2. Journal of Biological Chemistry, 283, 27916-27926.